Nateglinide Clinical Trials

• Double-Blind Comparison Between Mitiglinide and Nateglinide in Type 2 Diabetic Patients
  ClinicalTrials.gov Identifier: NCT00461617 - Active, not recruiting
  Diabetes
  
• The Effects of Nateglinide and Acarbose on the Post-Prandial Glucose Control in Type 2 Diabetic Patients
  ClinicalTrials.gov Identifier: NCT00437918 - Recruiting
  Diabetes Mellitus; Type 2 Diabetes Mellitus
  
• Long-term Study of Starlix+Diovan to Delay Type II Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00097786 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• A Pilot Study to Evaluate the Effects of Nateglinide Vs. Glibenclamide on Renal Hemodynamics and Albumin Excretion
  ClinicalTrials.gov Identifier: NCT00238472 - Completed
  Diabetes Mellitus, Type 2
  
• Safety and Efficacy of Nateglinide in Patients With Type 2 Diabetes Already Taking Insulin Glargine, Metformin and/or Pioglitazone or Rosiglitazone
  ClinicalTrials.gov Identifier: NCT00402909 - Completed
  Type 2 Diabetes
  
• Nateglinide: a Double Blind Add-on Study With Pioglitazone for Type 2 Diabetic Patients
  ClinicalTrials.gov Identifier: NCT00189774 - Completed
  Type 2 Diabetes Mellitus; Diabetes Mellitus, Type II
  
• Efficacy and Safety of Nateglinide Treatment in Renal Transplant Recipients
  ClinicalTrials.gov Identifier: NCT00319189 - Completed
  Renal Transplant Recipients; Posttransplant Diabetes Mellitus; Posttransplant Impaired Glucose Tolerance